… not associated with cancer therapies. In this Review, the known risk factors for treatment-associated
cardiovascular disease in women with breast cancer are described, and we also …

… Many patients with childhood- or adult-onset cancer are cured or live for ten years or longer
[… of adverse cardiovascular events in cancer survivors indicate that success in cancer care …

… Preventing radiation-induced heart disease is largely dependent on exposing the cardiac
tissue to the lowest effective dose of radiation, as cardiotoxicity increases linearly with …

… to the type of cancer, treatment, prognosis, and the patient's … cardiovascular risk and events
during cancer treatment. To date, long-term follow-up for heart failure after cancer treatment is …

… CV risk patients during and after cancer treatment. This could be an opportunity for an artificial
intelligence (AI) solution to automate the risk … at the time of breast cancer diagnosis, and …

… North America are a result of cardiovascular disease (CVD) or cancer [1, 2]. Despite the
progress and improved efficacy of today’s cancer therapies, the toxicities associated with cancer …

… cardiovascular effects of breast cancer therapy and recommendations for their diagnosis
and management during the cancer treatment … initiatives and how they inform clinical care. …

… The majority of anticancer therapies are associated with some CV … cardiac events. It is
critical however, that concerns about potential CV damage resulting from anticancer therapies …

… Understanding the different cardiotoxicities associated with breast cancer treatment is
vital to this approach, and therefore, this article seeks to provide an overview of this. …

… This narrative review explores the current evidence linking cardiovascular disease and cancer,
… Cancer and cancer treatment can accelerate the development of cardiovascular disease. …